2007
DOI: 10.1016/j.pharmthera.2007.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone: Therapeutic opportunities for neuroprotection and myelin repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
155
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 217 publications
(161 citation statements)
references
References 443 publications
5
155
0
1
Order By: Relevance
“…The observed effects of progesterone on inflammation reduction, swelling, and apoptosis have been proposed to be caused by regulation of gene transcription, the modulation of neurotransmitter receptors, and the activation of signaling cascades (Schumacher et al, 2007). Progesterone has been shown previously to modulate the activity of neurotransmitters, including positive modulation of c-aminobutyric acid type A (GABA A ) receptors, primarily by allopregnanolone, the active metabolite of progesterone (Belelli et al, 2002;Majewska et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…The observed effects of progesterone on inflammation reduction, swelling, and apoptosis have been proposed to be caused by regulation of gene transcription, the modulation of neurotransmitter receptors, and the activation of signaling cascades (Schumacher et al, 2007). Progesterone has been shown previously to modulate the activity of neurotransmitters, including positive modulation of c-aminobutyric acid type A (GABA A ) receptors, primarily by allopregnanolone, the active metabolite of progesterone (Belelli et al, 2002;Majewska et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…The suppression of allopregnanolone synthesis increases markers of cell proliferation, an effect that is ameliorated when the synthetic neurosteroid, alfaxalone, is used to replace the loss of the endogenous neurosteroid (Yawno et al 2009). In adult rat models of traumatic brain injury, allopregnanolone administration has also reduced the size of GFAP-positive astrocytes at the site of the experimental lesions (Djebaili et al 2005), and there is increasing evidence for the effectiveness of allopregnanolone in reducing lesion size and enhancing functional recovery in animal models of traumatic brain injury (Djebaili et al 2004, Schumacher et al 2007. In addition to the previously reported neuroprotective actions of allopregnanolone, this study provides evidence of delayed neurodevelopment in the presence of a low neurosteroid environment and suggests an important role of allopregnanolone in the regulation of developmental processes in the late gestation foetal brain.…”
Section: Discussionmentioning
confidence: 99%
“…There is increasing evidence that allopregnanolone has a neuroprotective function in both the adult (Djebaili et al 2004, He et al 2004, Schumacher et al 2007) and foetal brains (Yawno et al 2007(Yawno et al , 2009. Inhibition of allopregnanolone synthesis, using finasteride (a 5aR inhibitor), in foetal sheep increased the number of cells undergoing programmed cell death within the brain, and accentuated the cell death caused by asphyxia arising from transient umbilical cord occlusion (Yawno et al 2007).…”
Section: Introductionmentioning
confidence: 99%
“…19 Perhaps in the present experiments progesterone facilitated the release of trophic factors from nearby Schwann cells. 31,32,[45][46][47] Nerve sectioning plays a fundamental role in aberrant innervation, since it occurred even in animals implanted with silicone tubes. In our study, the synaptic connectivity between the nerve supply to the gastrocnemius muscle and the muscle itself seemed to be functional.…”
Section: Discussionmentioning
confidence: 99%